April 27, 2024

Archives for April 2011

Economic View: Needed: A Clearer Crystal Ball

In fact, some people view the recent crisis as just another “black swan event,” one of those outliers, as popularized by Nassim Taleb, that come out of the blue. And it’s clear that a lot of smart people simply didn’t see the housing bubble, the instability of our financial sector or the shock that came in 2007 and 2008.

But the theory of outlier events doesn’t actually say that they cannot eventually be predicted. Many of them can be, if the right questions are asked and we use new and better data. Hurricanes, for example, were once black-swan events. Now we can forecast their likely formation and path pretty well, enough to significantly reduce the loss of life.

Such predictions are a crucial challenge in economics, too, and they are why data collection need not be a dull or a routine field. If done correctly, it can be very revealing. The Dodd-Frank Act of 2010 created a Financial Stability Oversight Council with a research arm, the Office of Financial Research, to help confront systemic risks. Perhaps these new organizations will improve our knowledge, mirroring the progress we have seen with hurricanes.

Of course, there was already an organization that looked a bit like a leaner version of the oversight council, yet it did nothing effective to prevent the recent crisis. That is the President’s Working Group on Financial Markets, created by President Ronald Reagan after the stock market crash of 1987. The real hope for the new organization is its research office — but only if it is given enough resources. The law charges the new office with collecting data, standardizing it and “developing tools for risk measurement and monitoring.” Those tasks aren’t as minor and as technical as they may sound.

Armchair scientists will never get far; observation makes all the difference. Think of the advances that came with the microscope and telescope. So it is with measurements in economics, too.

When I wrote the second edition of my book “Irrational Exuberance” in 2005, I produced a century-long series of home prices, which revealed how unusual the housing-price boom was at the time. General talk about the nature of bubbles didn’t convince many people that a bubble was forming, but the data I collected did convince at least some that we were in a very risky and historically unparalleled situation.

Donald L. Kohn, the former vice chairman of the Federal Reserve Board, along with the board economists Matthew J. Eichner and Michael G. Palumbo, argued in a 2010 paper that a significant reason the financial crisis was not anticipated was that the board had no reliable information on two important variables. One, it said, was “the underlying credit risk associated with the rapid growth of home mortgages and a consequent increase in the vulnerability of borrowers to a downturn in home prices or incomes.” The other was the growth of financial vulnerability outside the traditional banking sector because of “a greater reliance on short-term funding for longer-term financial instruments.”

Such acknowledgments of information black spots are familiar. The Depression of the 1930s was blamed on a lack of knowledge, too, but one result was an improvement in our measurement systems.

The government’s National Income and Product Accounts data began as a reaction to the Depression. And the term “gross national product” first appeared in an article by Clark Warburton in 1934, amid the Depression’s darkest days.

It took years, however, to develop this concept. The new Keynesian economic theory provided the intellectual framework for integrating disparate sources of information. That was no easy task. The Commerce Department didn’t start publishing G.N.P. data until 1942 — backdating it to the beginning of the Depression in 1929. (In 1974, it restated it as gross domestic product, or G.D.P.)

The Federal Reserve started work on its Flow of Funds Accounts in the Depression as well. These accounts, which go beyond G.N.P. and show the flow of funds from each kind of financial institution to another, offer a much better picture of the kinds of instabilities that led to the Depression. This innovation took a long time, too. The Fed didn’t begin publishing these accounts until 1955, backdating them to late in the Depression, in 1939.

Eventually, these advances led to quantitative macroeconomic models with substantial predictive power — and to a better understanding of the economy’s instabilities. It is likely that the “great moderation,” the relative stability of the economy in the years before the recent crisis, owes something to better public policy informed by that data.

Since then, however, there hasn’t been a major revolution in data collection. Notably, the Flow of Funds Accounts have become less valuable. Over the last few decades, financial institutions have taken on systemic risks, using leverage and derivative instruments that don’t show up in these reports.

Some financial economists have begun to suggest the kinds of measurements of leverage and liquidity that should be collected. We need another measurement revolution like that of G.D.P. or flow-of-funds accounting. For example, Markus Brunnermeier of Princeton, Gary Gorton of Yale and Arvind Krishnamurthy of Northwestern are developing what they call “risk topography.” They explain how modern financial theory can guide the collection of new data to provide revealing views of potentially big economic problems.

TODAY, our prosperity depends on finance, and on its associated disciplines of accounting and macroeconomics. The financial crisis didn’t demonstrate their bankruptcy, as some would say. We should respond just as we did to the Depression, by starting the long process of redefining our measurements so we can better understand the risk of another financial shock.

The past suggests that this project will take many years to complete. But it will be worth the effort. 

Robert J. Shiller is professor of economics and finance at Yale and co-founder and chief economist of MacroMarkets LLC.

Article source: http://feeds.nytimes.com/click.phdo?i=95f4c3a0e284ff3b8d85e28f28976975

Slipstream: Data Privacy, Put to the Test

To the catalog of corporate “bigs” that worry a lot of us little people, add this: Big Data.

It was not a good week for those who guard their privacy. First, we learned that Apple and Google have been using our smartphones to collect location data. Then Sony acknowledged that its PlayStation network had been hacked — the latest in a string of troubling data breaches.

You’d have to be living off the grid not to realize that just about everything there is to know about you — what you buy, where you go — is worth something to someone. And the more we live online, the more companies learn about us.

But to what extent do others have a right to share and sell that information? That is the crux of a data-mining case that had arguments last Tuesday before the Supreme Court.

The case, Sorrell v. IMS Health, is ostensibly about medical privacy: Vermont passed a law in 2007 that lets each doctor decide whether pharmacies can, for marketing purposes, sell prescription records linking him or her by name to the kinds and amounts of drugs prescribed. State legislators passed the law after the Vermont Medical Society said that such marketing intruded on doctors and could exert too much influence on prescriptions.

But three health information firms, including IMS Health and Verispan, along with a pharmaceutical industry trade group, challenged the law, saying it restricted commercial free speech. Access to prescription records, IMS Health says, helps pharmaceutical companies market efficiently to doctors whose patients would most benefit from specific drugs.

Now the justices are to decide whether the Vermont law is constitutional.

But with the recent headlines about privacy invasion — the PlayStation hack followed a recent breach at the online marketing company Epsilon that exposed e-mail addresses of customers of Citibank, Walgreens, Target and other companies — the Vermont case is tapping into a much broader conversation about consumer protection and informed consent.

The case raises questions about who is collecting, managing, storing, sharing and selling all that data. Just as important, privacy advocates say, it raises questions about whether data brokers are adequately safeguarding it.

People generally don’t have much control over who collects and sells information about them. Moreover, says Christopher Calabrese, a legislative counsel at the American Civil Liberties Union, they also don’t even know the names of the data brokers who compile those electronic profiles.

And, so, consumer advocates are setting their sights on Big Data.

“Without government intervention, we may soon find the Internet has been transformed from a library and playground to a fishbowl,” Mr. Calabrese testified in March during a Senate hearing on consumer privacy, “and that we have unwittingly ceded core values of privacy and autonomy.”

There are a few laws, like the Video Privacy Protection Act, that prohibit businesses from releasing personally identifiable records, like video rental histories, without customer consent. The Digital Advertising Alliance, a coalition of online marketing groups, introduced a program last year that notifies consumers about online tracking and allows them to opt out of advertising tailored to them.

The Vermont law amounts to a kind of do-not-call option for doctors who may welcome visits from pharmaceutical sales reps but don’t want drug marketing based on their own prescription records.

That marketing practice is possible because pharmacies, which are required by law to collect detailed information about prescriptions they fill, can sell doctor-specific prescription records to data brokers. (According to federal privacy regulations, personal information about patients, like names and addresses, must be removed before the records can be sold for marketing.) Firms like IMS Health then combine the records, and pharmaceutical reps often use them to tailor presentations to individual doctors.

The central concern is privacy — of both doctors and their patients. While pharmacies remove the names of patients before selling the records, those names are replaced with unique codes that track patients over time from doctor to doctor, according to the Vermont complaint. That means data firms could create a profile that includes a person’s prescriptions as well as the names of the pharmacies and dates at which the person picked up the medications, says Latanya Sweeney, a visiting professor of computer science at Harvard.

“It ends up building a detailed prescription profile of individuals,” says Professor Sweeney, whose research on data re-identification was cited by several briefs in the case. “Those extended profiles tend to be very unique.”

The concern, she says, particularly in a small state like Vermont, is that a nameless prescription record could theoretically be enough to identify someone who might not want others to know that he takes, say, anti-depressants. Moreover, Professor Sweeney argues, data miners could collate those files with public information, like voter registration and hospital discharge records, to link prescriptions to specific people.

Federal health privacy regulation, she says, does not protect patient records once they have been de-identified. Nor does the law prohibit re-identification.

But IMS Health says it isn’t aware of any case of re-identifying patients whose prescription records were de-identified in accordance with federal rules. The company says it doubly encrypts each patient’s identity and gives the encryption keys to several third parties — meaning that no single entity can decode a file by itself, says Kimberly Gray, chief privacy officer at IMS Health.

The company typically sells combined reports that show how many patients received a certain drug from a certain doctor, but not the specific drugstores those patients frequent, Ms. Gray says. IMS never uses public information or outside data sets to try to re-identify patients, she says, and when it does provide encoded patient histories to others for research purposes, it prohibits those third parties from making such attempts.

“We would never want to re-identify someone,” Ms. Gray says. “No good can come from that.”

Still, it is hard to prevent people from trying to re-identify patients, says Lee Tien, a staff lawyer at the Electronic Frontier Foundation, a digital civil liberties group that filed a brief in support of Vermont. It would be easier, he says, if Congress passed a law that went further than Vermont’s, giving people the right to consent before their encrypted prescription records were sold for marketing purposes.

“In Vermont, the doctor can decide,” Mr. Tien says. “But we’d prefer it if the patient were able to say, ‘Don’t sell my data.’ ” 

Article source: http://feeds.nytimes.com/click.phdo?i=a3d30a1287df0ba99b42dad68cd07ab7

Corner Office: Lars Bjork: Order Is Great. It’s Bureaucracy That’s Stifling

 This interview with
Lars Bjork
, C.E.O. of QlikTech, a data software company, was conducted and condensed by
Adam Bryant
.

Q. Do you remember the first time you were somebody’s boss or manager?

A. It was in 1984.  I had the opportunity to work in construction in New York, coming right out of undergrad.  I was sick and tired of school at the time. I didn’t want to study anymore.  My uncle had built one of the largest construction companies in the world, so he got me a job on the Throgs Neck Bridge in New York as an assistant supervisor on site. 

I was 22, and the men were double my age and tough.  And I think the only way I could go about it was just walk up and try to speak to them and try to earn their respect, which I did.  It took some time.  It was rough at the beginning, but I learned a lot from that.  It was hard, tough, but a very fair environment.

Q. How did you handle it?

A. They looked at me skeptically.  Who is this kid just out of school?  He doesn’t know anything about what you really do on a construction site like this.  But I was a foreigner, and they were curious, so they said, let’s hear him out, see who he is. 

Then it just comes down to proving yourself — things you give them advice on or things that you tell them that are solid and sound, and weren’t just pulled out of the air.  I’ve always been very open toward people.  I never kept anything to myself, and I just explained to people what was on the agenda for the day, and why we were doing this.

Q. What has been your approach to leadership?

A. I have never seen myself as a leader, someone who says I’m going to become a C.E.O.  I never did that.  And that goes even for where I am now.  I didn’t start as C.E.O. at this company. It was never something that I put on a map, where I said, I’m going to get there.  It’s more the result of me very much earning the respect of the people I work for, and they said, this is a guy we’re going to promote.  Q. What else?

A. I’ve always been competitive, and I’m also curious.  I want to learn things, and that’s why, early in life, I put myself in challenging situations, like coming to the United States from Sweden to work here. I’m also more humble today than I was 20 years ago.  I am by no means the expert.  I’m not the smart guy in the room.  I might have an ability to bring people together and get the best team or have a sense of what’s needed. Being the coach — that’s sort of what it’s been for me.

Q. What were some other big lessons?

A. I once worked for somebody who managed in such a terrible way that I decided to never work with people who treat people badly.  Life is too short for that.  Let’s work with people who appreciate you and you appreciate them. It was such a terrible experience, so I left the company because I didn’t want to be associated with that. 

For me, it’s super-important — if I love my job, why wouldn’t I want the same thing for my co-workers? They will feel good and they will enjoy working and they will stay, and I know it will show up in the results as well.  There is no other way to do it.  Motivated people will go way further than anyone else. 

Q. Tell me about the culture at your company.

A. We developed five core values that we live by.  The first one is “challenge,” because we are a disruptive software company. Always challenge the conventional, because if you follow others, you can at best be No. 2.  And if you want to win, you’ve got to find your own way to the top. And we challenge each other at QlikTech, because if you’re complacent, you’re not going to survive. 

The second one is move fast — because we are building a hypergrowth company. It’s O.K. to make mistakes, just don’t make the same mistakes.  Learn from them. The third one is, be open and straightforward.  What that means is just be open if you think something is wrong.  We hear everyone out.  It’s important that everything is on the table, because somebody might have something brilliant to say.  But when we leave the room and we’ve decided on one thing and your view might not be incorporated in that, you still have to respect the decision.   

The fourth one is teamwork for results.  This is not about the individual.  This is about the team, the power of the team.  In our company today, we have 28 offices in 23 countries, so our team is a virtual one. You reach out and you speak to people everywhere, and you learn a lot from people that way, because there are a lot more similarities between cultures than you might think. 

The fifth one is take responsibility. You’re given authority to be part of a lot more than just your position, but some responsibility also comes with it.  And if you want to grow fast, you have to put into people’s DNA the idea of being cost-conscious. That’s why we all still travel coach.

Article source: http://feeds.nytimes.com/click.phdo?i=48ccfc818129c20ea7493f19421c5abc

Law Students Lose the Grant Game as Schools Win

To keep her grant, all that Ms. Leumer had to do was maintain a grade-point average of 3.0 or above — a B or better. If she dipped below that number at the end of either the first or the second year, the letter explained, she would lose her scholarship for good.

“I didn’t give it much thought,” she said. “I didn’t think it would be a challenge.”

Her grades and test scores were well above the median at Golden Gate, which then languished in the bottom 25 percent of the U.S. News and World Report annual rankings of law schools.

How hard could a 3.0 be? Really hard, it turned out. That might have been obvious if Golden Gate published a statistic that law schools are loath to share: the number of first-year students who lose their merit scholarships. That figure is not in the literature sent to prospective Golden Gate students or on its Web site.

But it’s a number worth knowing. At Golden Gate and other law schools nationwide, students are graded on a curve, which carefully rations the number of A’s and B’s, as well as C’s and D’s, awarded each semester. That all but ensures that a certain number of students — at Golden Gate, it could be in the realm of 70 students this year — will lose their scholarships and wind up paying full tuition in their second and third years.

Why would a school offer more scholarships than it planned to renew?

The short answer is this: to build the best class that money can buy, and with it, prestige. But these grant programs often succeed at the expense of students, who in many cases figure out the perils of the merit scholarship game far too late.

On the Golden Gate campus recently, a group of first-year students at risk of losing their scholarships were trying to make sense of the system. Most declined to be identified for this article because criticizing the school seemed, at minimum, undiplomatic. But the phrase “bait and switch” came up a lot. Several assumed that they were given what is essentially a discount to get them in the door.

“I had a friend once who told me that hunting is a sport,” said one Golden Gate merit grant winner who anticipated coming up shy of a 3.0 average. “I said, ‘Hunting is not a sport.’ He said: ‘Sure it’s a sport. It’s just that the animals don’t know they’re in a game.’ That’s what it feels like to be a law student these days. You have no idea you’re in a game.”

The school’s dean, Drucilla Stender Ramey, declined to say exactly how many students would lose their scholarships this year, suggesting that doing so would violate the privacy rights of the students. She acknowledged, though, that lost merit scholarships have been the source of much campus misery.

“Of course some students are disappointed,” she said. “I thought I’d be 5-foot-10, and I’m 4-11. But if you gave students sodium pentothal,” also known as the truth serum, “they’d say, ‘This is a new and very difficult undertaking, the school will support me as best they can and, hopefully, with hard work and good luck, I’ll be able to retain my scholarship.’”

Nobody knows exactly how many law school students nationwide lose scholarships each year — no oversight body tallies that figure — but what’s clear is that American law schools have quietly gone on a giveaway binge in the last decade. In 2009, the most recent year for which the American Bar Association has data, 38,000 of 145,000 law school students — more than one in four — were on merit scholarships. The total tab for all schools in all three years: more than $500 million.

It’s a huge sum, particularly when you realize that merit scholarships were exceptionally rare at law schools a mere generation ago. But given that many students lose their grants after the first year, the question is this: What exactly are law schools buying with all of that money?

JERRY ORGAN, a professor at the University of St. Thomas School of Law in Minneapolis, has been one of the few academics to study law school merit scholarships. Six years ago, after a conversation with the school’s director of admissions, Professor Organ learned that the number of applicants weighing merit scholarship offers had soared since his days as an applicant in the early 1980s.

Article source: http://feeds.nytimes.com/click.phdo?i=70e0f944522519672406ab546e3860b9

In China, Art Is Making a Commercial Statement

The tricked-out design for new T-shirts in China was created by Chen Leiying, a 27-year-old artist known as Shadow Chen who lives in the coastal city of Ningbo. She is not even an employee of the company, but multinationals like Adidas are beginning to turn to young creative types like her to dream up images and logos for the under-30 set in China, a group that is 500 million strong.

Call them China’s youth whisperers. From Harbin in the north to Guangzhou in the south, young artists, musicians and designers are being tapped to make companies’ brands cool.

Like its counterparts elsewhere, this arty crowd sometimes looks and acts unconventional — but it’s not with political ends in mind. These young artists tend to set aside politics for commerce, and the promise of attractive paydays from foreign businesses.

At the center of this experiment is NeochaEdge, the first and only creative agency of its type in China. It was started in 2008 by two Americans, Sean Leow and Adam Schokora, to showcase the work of illustrators, graphic designers, animators, sound designers and musicians from across China. It now has 200 member-artists; NeochaEdge pays them per project to work on campaigns and product designs for brands like Nike, Absolut vodka and Sprite.

Adidas wants to be cool, “and the only way to be cool is to appeal to young people,” says Jean-Pierre Roy, who until recently helped oversee product development in China for Adidas. To help enhance that image, Adidas selected four Chinese artists, including Ms. Chen, to design 20 graphics for its new T-shirts.

Over the last year, members of the agency have also produced a soundtrack and a streetlight graffiti show for Absolut, designed sneakers for the Jimmy Kicks shoe company and created content for an e-magazine for Nike about basketball culture in China. And by the end of this year, NeochaEdge will also become a virtual art gallery, selling artwork from its artists through its Web site.

“You can’t just stroll into China and see who is a hot artist,” says Mr. Roy (who now works for Oakley, the eyewear company, in Shanghai). “It’s all still a little underground.” So Mr. Schokora, 30, and Mr. Leow, 29, have become trusted guides.

“There are not many young Americans who speak fluent Mandarin and are as much at home talking to chief marketing officers as they are talking to graffiti artists in Guangzhou,” says Paul Ward, head of operations for Asia at the advertising agency Bartle Bogle Hegarty in Shanghai, which has collaborated with NeochaEdge on projects over the last year.

Members of NeochaEdge are a far cry from Ai Weiwei, the 53-year-old Chinese artist and dissident who was recently detained by the government. These graphic designers, sound artists and animators have other motivations.

“They want to advance their careers, not challenge the political establishment,” Mr. Leow says. “Commercial art has rarely, if ever, contained dissent.”

Defne Ayas, an art history instructor at New York University in Shanghai, put it this way in an e-mail: “For some artists in this younger generation, the new political has become the ‘market.’ They tend to be curious and friendly to the market; they don’t want to miss out on its opportunities.”

In fact, the government is putting its muscle behind companies like NeochaEdge. In Shanghai alone, the government has created more than 80 creative industry zones for 6,000 businesses. In 2008, the Shanghai municipal government named NeochaEdge as “one of the top representatives of the creative industry.”

SO how did two young guys from the United States — Mr. Schokora grew up in Detroit and Mr. Leow in Silicon Valley — end up becoming conduits to the young, creative community in China?

Before founding the company, Mr. Leow, who studied Chinese as an undergraduate at Duke, was living and working in Shanghai as a business consultant and consuming large quantities of Chinese culture.

“I was going to a lot of art exhibitions and indie rock shows, and I always thought that China was all about imitation and nothing creative, but I was wrong,” Mr. Leow says. That prompted the idea to develop a social networking site for creative types in China called neocha.com. (“Cha” is Chinese for tea.) There was just one problem: revenue from advertisers was not coming in.

At the same time, Mr. Schokora, who has been living in China since 2003, was working as a manager of digital and social media for Edelman, the global communications firm.

“I knew about neocha.com even before I met Sean,” Mr. Schokora recalls. “It was pretty much the only site out there aggregating what young, creative kids in China were doing online.” In 2007, Mr. Schokora and Mr. Leow met at a music festival in Shanghai, and the meeting quickly evolved into a partnership.

Article source: http://feeds.nytimes.com/click.phdo?i=da2a805847a94dace7b8300b97302791

Patient Money: Containing the Costs of Pet Care

Last year the Nocella family adopted two puppies, a pit bull mix named Pokie and a “puggle” named Browny. Since then, Ms. Nocella estimates, the family has spent as much as $5,000 on veterinarian bills.

The dogs have had routine checkups and shots, of course. But then there were unexpected costs: Pokie arrived with a bad case of worms and kennel cough; some strange bumps on her paws turned out, after $700 worth of tests, to be warts. Browny has severe allergies and requires frequent trips to the vet.

Last November, Pokie swallowed Advil pills, which are toxic to dogs. She went into renal failure and required emergency treatment overnight in a nearby animal hospital. The treatment was successful and Pokie is fine, but the incident set the Nocellas back $2,300.

Pet owners like Ms. Nocella are spending more on veterinarian bills than ever before. The American Pet Products Association estimates that Americans will spend $12.2 billion on veterinary care this year, up from $11 billion last year and $8.2 billion in 2006.

Advances in veterinary medicine mean more extensive, and expensive, treatments are available for animals, but even ordinary costs like flea and tick protection can add up quickly. Here are some ways to curb those costs while still giving your pet the best of care.

LOW-COST ALTERNATIVES Local shelters often offer free or low-cost spaying and neutering for dogs and cats, said Dr. Louise Murray, vice president at the American Society for the Prevention of Cruelty to Animal’s Bergh Memorial Animal Hospital in New York and author of “Vet Confidential.” To find a shelter near you, check the A.S.P.C.A. Web site at www.aspca.org/pet-care/spayneuter.

Shelters where pets can be adopted may offer low-cost vaccinations and checkups. Mobile clinics, usually sponsored by local governments or animal protection agencies, also provide routine pet care for far less than a traditional vet would charge.

Veterinarian schools are another good source of low-cost care. Students are carefully supervised by qualified veterinarians, so pets receive quality care — everything from heartworm tests to major surgery, often for as little as a third of the price at a veterinarian’s office.

THE RIGHT VACCINES Keeping up with a pet’s shots will save money, not to mention misery, in the long run by preventing many serious illnesses. But that does not mean a pet needs every vaccine available.

“A corgi who lives on the Upper East Side doesn’t need the same protocol as a Labrador in Connecticut,” Dr. Murray said. “Your veterinarian should customize a vaccine plan that fits your pet.”

A HEALTHY DIET Many vets sell prescriptions and high-quality pet food, but the same brands are sold for much less at many pet supply stores or Web sites. Still, do not skimp on quality.

“Cats, for example, are carnivores and aren’t meant to eat carbohydrates,” Dr. Murray said. “Feeding them only the cheap dried food can lead to diabetes or blockages that will cost you a lot more in the long run than the price you’ll pay for the right food.”

DRUG DISCOUNTS If a pet needs regular medication, discount chains such as Costco can be cheaper than a regular drug store or the vet’s office, said Dr. Sharon Friedman, a veterinarian at the Berkley Animal Clinic in Berkley, Mich. But consult a veterinarian first, she advised, to be sure to buy the right medicine at the right dosage.

On the other hand, do not assume that tick and flea treatments or heartworm medications are cheaper at the big discount chains. Manufacturers want to distribute these medicines through veterinarians’ offices, so they often offer promotions and discounts there that are not available elsewhere.

“One company recently offered two free tick and flea treatments if you bought six doses. That worked out to be less expensive than PetMeds, a popular online store, or Costco,” Dr. Friedman said. “It often pays to ask.”

Many Web sites sell high-quality pet medications at good prices, but a recent Food and Drug. Administration. investigation caught some sites selling counterfeit, unapproved or expired drugs. Beware of any site that sells medications without requiring a veterinarian’s prescription.

The F.D.A. also recommends that consumers look for sites accredited as a Veterinary-Verified Internet Pharmacy Practice Site, part of a voluntary accreditation program.

CONSIDER INSURANCE Pet health insurance is a booming industry, growing more than 20 percent every year, although only an estimated 3 percent of pet owners have bought policies. While Ms. Nocella has never seriously considered buying pet insurance, she does acknowledge it might have come in handy the day Pokie ate the Advil.

But like health insurance for humans, pet insurance can be complicated and highly restricted. Some policies will not cover older pets or genetic conditions that certain breeds are known to have, such as hip dysplasia in retrievers.

Others limit coverage to only one treatment per illness. So if your dog develops asthma, for instance, some policies will cover just the first trip to the vet although treatment will require multiple visits.

Prices for pet insurance can range from $12 to $50 a month, depending on the type and age of the pet and any pre-existing conditions. In almost all cases the pet owner pays up front, then files a claim for reimbursement.

Costs are higher to insure older, sicker pets, or for policies that cover preventive care, such as vaccines and veterinarian office visits.

Many pet owners prefer to save for unexpected vet expenses in an emergency fund instead of paying premiums for coverage they may not use. Dr. Murray suggested putting away a little each week until savings reach $2,000 to $3,000.

“That’s the minimum you’ll need if a serious situation arises and your pet needs lifesaving care,” she said.

Article source: http://feeds.nytimes.com/click.phdo?i=9d0e3b06f3ecbfa58c95de0dd2968f8b

A Name for a Contractor, a Meatball Distributor, Perchance a Mall

No longer will the white whale of a mall be known as Xanadu Meadowlands, which presumably took its first name from Coleridge’s “Kubla Khan,” or the ancient city in Inner Mongolia, or the 1980 belly-flop of a film starring Olivia Newton-John. Now it is to be American Dream@Meadowlands, a name that arguably manages to be at once patriotic and nondescript.

With its rechristening, the complex not only sheds what has become the Ishtar of mall names, but it also joins at least 107 New Jersey businesses named “American Dream,” or some variation of that, according to state corporate records. Indeed, the Garden State is teeming with American Dream companies of all stripes and may rightly claim some proprietorship of the term, which appears in the first line of the state’s unofficial anthem, “Born to Run.” (The first line of the song “Xanadu” is “A place where nobody dared to go.”)

New Jersey is home to American Dream custom cycle, limousine and food shops; several American Dream homebuilders and real estate outfits; and, coming full circle, at least one American Dream foreclosure specialist. There are American Dream travel agents, green card services and houseware shops, and a limited liability corporation called American Dreamz, which may or may not be named after the Hugh Grant movie from 2006.

Few of the state’s American Dream proprietors said they felt threatened by sharing a name with the behemoth mall.

“I chose the name American Dream because I came to the U.S. from Portugal with one dream — to get a better life,” said Ivan Diogo, 28, a subcontractor who started his business, American Dream Mechanical Contractors, one year ago. The anemic economy forced Mr. Diogo to shutter a small storefront and send his two employees home, so his realization of the American dream, he said, is “halfway true.”

Several American Dream proprietors said their choice of the name was defiantly optimistic.

Mark A. Faccone and a business partner used the name for their wealth management firm in affluent Brick after being told it was folly to strike out on their own. “We both worked for another firm, and it seemed like we were both drones,” Mr. Faccone said.

Vincent Brian Savarese, 53, joined other partners to open American Dream Realty in Carneys Point two months ago, after the real estate office he worked at with his father, Enzo, an Italian immigrant, closed because of a drop in business. “Now more than any time that I can think of, home ownership is a tricky thing,” Mr. Savarese said, “but it’s still the American dream.”

Not that the name American Dream guarantees success or necessarily brings with it joy. “Oh great,” deadpanned Paul Frank, 67, a home inspector from Clinton, after learning about the new name of the mall.

Mr. Frank, who owns the American Dream home inspection company, said he had at one time been barraged with phone calls because of a program for first-time home buyers called American Dream, and so he had to get rid of his 800 number.

While his business has suffered of late, with his home inspections going to 18 a year from 250, he has no plans to change its name. “That’s how people know me,” Mr. Frank said.

One businessman who brightened at Xanadu’s new name is John Wollerman, owner of the New American Dream Corporation in Lodi. It sells Tuscan olive oil, ravioli and meatballs made by Johnny DeCarlo, his son, to restaurants and supermarkets.

Mr. DeCarlo, the professed “meatball king of New Jersey,” also runs meatball carts and is hoping to open a meatball kiosk at the mall. Maybe a case of mistaken identity, Mr. Wollerman said, would help his son’s venture along.

“If people are calling me thinking I’m the mall, great,” Mr. Wollerman said. “Everything opens up a door.”

Article source: http://feeds.nytimes.com/click.phdo?i=b936b3c5026bd485aaa66f916c4fb6b5

Jury Rejects Missouri Hospitals’ Case Against Tobacco Firms

About 40 Missouri hospitals sued the Philip Morris unit of the Altria Group, the R. J. Reynolds Tobacco Company, the Lorillard Tobacco Company and other cigarette makers in 1998, claiming they manipulated the nicotine content in cigarettes and misrepresented the health effects of smoking. The hospitals were seeking more than $455 million in damages, ranging from about $300,000 for some hospitals to $86.4 million for the Truman Medical Center in Kansas City, Mo.

The hospitals argued that the industry’s actions had raised spending for unreimbursed and uncompensated tobacco-related health care. The tobacco companies denied any responsibility for patient care costs at the hospitals or any financial losses by the hospitals. The jury, in Missouri Circuit Court in St. Louis, rejected the hospitals’ claims on a 9-3 vote Friday in the seventh day of deliberations.

“The jury correctly rejected the entirety of the hospital’s claims,” Murray Garnick, associate general counsel for Altria Client Services, said in a statement. The jury agreed with Philip Morris “that ordinary cigarettes are not negligently designed or defective,” he said.

The hospitals haven’t decided whether to appeal, their lawyer, Kenneth Brostron, said.

The case is the third such health care cost-recovery claim to reach trial, according to regulatory filings by Altria. The tobacco industry won the first, in Ohio, in 1999. The second initially resulted in a $17.8 million award for a health insurer by a New York jury in 2001. That was reversed on appeal in 2004.

The Missouri suit, which did not include patients as plaintiffs, went to trial in January.

The hospitals, which provide care to indigent patients and others who do not pay, represent the majority of licensed, adult acute care hospital beds in Missouri, according to the complaint. The hospitals said medical ethics required them to serve people in need regardless of their ability to pay.

Tobacco companies should reimburse the hospitals for care provided to patients who were unable to pay and were suffering from tobacco-related illness, the plaintiffs said. Hospitals also should “recover the increased costs incurred to providing all health care services” as a result of tobacco use and exposure to tobacco smoke, according to the complaint.

Article source: http://feeds.nytimes.com/click.phdo?i=941f101f82b5250f5cb520b148566767

Merck’s Quarterly Profit Surges on Sales and Cost Savings

The results beat Wall Street expectations and suggest drug sales and cost savings from acquiring Schering-Plough were starting to pay off.

Merck shares rose 18 cents Friday to close at $35.95. Net income in the quarter was $1.04 billion, or 34 cents a share, up from $299 million, or 9 cents a share, in 2010’s first quarter.

Revenue edged up 1 percent to $11.58 billion. That includes several billion dollars from products added in the Schering-Plough acquisition in November 2009. Excluding numerous one-time items, net income was $2.86 billion, or 92 cents a share.

On that basis, analysts had forecast earnings of 84 cents a share and revenue of $11.38 billion. Analysts typically exclude one-time items in their estimates.

The $1.82 billion in net charges included $1.58 billion in merger-related write-downs on the value of assets and research, $126 million in restructuring costs and a $500 million payment to settle arbitration with Johnson Johnson over the rights to two drugs. A year ago, Merck had charges totaling $2.31 billion.

Merck, based in Whitehouse Station, N.J., raised the bottom end of its 2011 profit forecast by 2 cents, predicting $3.66 to $3.76 a share, or $2.04 to $2.39 including one-time charges.

Production costs fell 22 percent to $4.06 billion, partly because Merck has sold some factories.

A Jeffries Company analyst, Ian Hilliker, wrote to investors that the higher revenue and lower-than-expected costs gave Merck a strong “earnings beat.”

Top-performing drugs included Singulair and Januvia, plus some drugs acquired with Schering: the allergy spray Nasonex and Remicade for immune disorders. Their growth was partly offset by a $356 million drop in revenue from two former blockbuster heart drugs, Cozaar and Hyzaar, caused by generic competition.

Januvia and Janumet, a pill that combines Januvia with the generic diabetes drug metformin, had combined quarterly sales that topped $1 billion for the first time, up 47 percent.

Total pharmaceutical revenue rose 2 percent to $9.82 billion. Two units Merck acquired with Schering, animal health and consumer health, also performed well. Animal health revenue rose 7 percent and consumer health 6 percent, on strong sales of Claritin allergy pills and Coppertone sun care products.

Article source: http://feeds.nytimes.com/click.phdo?i=09eac9cc0ab8e507763c4b10818d1f30

Your Money: The Changes to Save a Big Idea

In fact, he spent about a decade working on it, finally succeeding when the Class Act, short for Community Living Assistance Services and Support, became law as part of last year’s landmark health insurance package.

The Class Act promises a lot: eligibility for most people, no matter their health status, as long as they are working at least a little; a benefit of at least $50 or so a day that lasts until death if necessary; and a premium structure that will offer big discounts for lower-income people but still won’t require any federal money.

This all turned out to be a bit too optimistic. In recent months, Kathleen Sebelius, the secretary of health and human services, has said that it will be difficult to make the offering both affordable and actuarially sound without some alterations.

She and her staff are making some changes, and the law gives them a certain amount of leeway. Their ultimate challenge is to make sure that the premium is not so low that there won’t be enough money to pay claims. But it also cannot be so high that it will scare off the young, healthy people who could subsidize all of the infirm people attracted to the plan’s generous eligibility rules (or frighten the employers of younger adults, who might encourage them to sign up).

Plenty of politicians are furious about the fact that something like this became law without the long-term numbers adding up. The far more interesting question, however, is why Senator Kennedy felt this law was necessary in the first place.

Here’s the blunt truth: Medicare generally won’t pay for as much nursing home or in-home care as many people think it will. Your cash savings may well be insufficient, especially if you want to leave plenty of money for a spouse who may outlive you. Your family may not be willing or able to take care of you. And if you do spend all of your assets to qualify for Medicaid, there’s no guarantee Medicaid will pay for the quality of care you want and do so close to friends or family.

So we better hope that the Class Act works and helps lots of Americans. Because if it doesn’t, plenty of people will be right back in denial-land again.

That said, there are some people who have already purchased long-term care insurance from a commercial company. Limra, a market research firm, figures there are about seven million of them.

Some buy it out of an abundance of caution, while others do it because their employers offer subsidized premiums as a benefit. Many others have seen family members spend hundreds of thousands of dollars on care or struggled to provide care themselves when there was no money left.

Even so, the insurance companies can make this a tough product to love, given their unexpected price jumps or occasional outright abandonment of the business.

How can the federal government possibly hope to do better? There are at least three ways.

First, it can enlist the help of employers, who could each make the government plan available to many thousands of employees.

According to an Aon Hewitt survey of over 1,300 large employers, 50 percent already made long-term care insurance available in 2010. But would those employers really want to replace what they have with a government program that would probably offer a lower level of benefits? Or would they offer it alongside their current plans?

As for the half of employers who do not offer any plan now, will their wary human resources executives really be first in line for a new government program?

The second way to potential success here is through automatic enrollment: getting those employers who do sign on to put every employee in the government plan and let individuals opt out later if they so choose.

The Class Act specifically mentions this possibility, though it does not seem to require it. The idea comes straight from the 401(k) playbook. According to an estimate from David L. Wray, president of the Profit Sharing/401k Council of America, which represents the interests of employers, about 38 percent of employees who have access to 401(k) plans work for employers who automatically enroll new workers.

Nobody, however, currently makes their employees buy long-term care insurance, according to Guy Bertsch, vice president for long-term care operations at Unum, which claims to sell far more policies through the workplace than any other company.

The authors of the Class Act were clearly worried about what would happen if employers did not sign everyone up automatically, though. Indeed, at employers that do not provide long-term care insurance free to everyone but still make it available for employee purchase, voluntary buy-in tends to be below 10 percent, Mr. Bertsch said.

Finally, there’s the possibility of rebranding the product to make it more relevant to young adults. Connie Garner, a former member of Senator Kennedy’s staff who worked closely with him on the Class Act, says she believes long-term care insurance has an image problem. “People think it’s for the lady with the blue hair in a wheelchair,” she said.

Ms. Garner, who is a nurse practitioner and now runs an advocacy group called AdvanceClass, speaks to groups about the fact that young adults who see themselves as invincible are only one dive into shallow water away from needing in-home care for the rest of their lives. That, she said, often moves parents in the audience to volunteer to pay for any premiums for their children, given that they would be discounted in the Class Act’s plan.

Article source: http://feeds.nytimes.com/click.phdo?i=f6e0c512afc72f56645e8a9c3c89f8ad